Your browser doesn't support javascript.
loading
Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer's Disease Drug Candidate.
Lindberg, Mattias F; Deau, Emmanuel; Miege, Frédéric; Greverie, Marie; Roche, Didier; George, Nicolas; George, Pascal; Merlet, Laura; Gavard, Julie; Brugman, Sander J T; Aret, Edwin; Tinnemans, Paul; de Gelder, René; Sadownik, Jan; Verhofstad, Eva; Sleegers, Dennis; Santangelo, Sara; Dairou, Julien; Fernandez-Blanco, Álvaro; Dierssen, Mara; Krämer, Andreas; Knapp, Stefan; Meijer, Laurent.
Afiliación
  • Lindberg MF; Perharidy Research Center, Perha Pharmaceuticals, 29680 Roscoff, Bretagne, France.
  • Deau E; Perharidy Research Center, Perha Pharmaceuticals, 29680 Roscoff, Bretagne, France.
  • Miege F; Edelris, Bâtiment Bioserra 1, 60 Avenue Rockefeller, 69008 Lyon, France.
  • Greverie M; Perharidy Research Center, Perha Pharmaceuticals, 29680 Roscoff, Bretagne, France.
  • Roche D; Edelris, Bâtiment Bioserra 1, 60 Avenue Rockefeller, 69008 Lyon, France.
  • George N; Oncodesign, 25-27 Avenue du Québec, 91140 Villebon-sur-Yvette, France.
  • George P; Perharidy Research Center, Perha Pharmaceuticals, 29680 Roscoff, Bretagne, France.
  • Merlet L; Team SOAP, CRCI2NA, Nantes Université, Inserm, CNRS, Université d'Angers, 8 Quai Moncousu, 44007 Nantes Cedex 1, France.
  • Gavard J; Equipe Labellisée Ligue Contre le Cancer, 75013 Paris, France.
  • Brugman SJT; Team SOAP, CRCI2NA, Nantes Université, Inserm, CNRS, Université d'Angers, 8 Quai Moncousu, 44007 Nantes Cedex 1, France.
  • Aret E; Equipe Labellisée Ligue Contre le Cancer, 75013 Paris, France.
  • Tinnemans P; Institut de Cancérologie de l'Ouest (ICO), Boulevard Professeur Jacques Monod, 44800 Saint-Herblain, France.
  • de Gelder R; Symeres, Peelterbaan 2, 6002 NK Weert, The Netherlands.
  • Sadownik J; Symeres, Peelterbaan 2, 6002 NK Weert, The Netherlands.
  • Verhofstad E; Institute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.
  • Sleegers D; Institute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.
  • Santangelo S; Symeres, Peelterbaan 2, 6002 NK Weert, The Netherlands.
  • Dairou J; Symeres, Peelterbaan 2, 6002 NK Weert, The Netherlands.
  • Fernandez-Blanco Á; Symeres, Peelterbaan 2, 6002 NK Weert, The Netherlands.
  • Dierssen M; Symeres, Peelterbaan 2, 6002 NK Weert, The Netherlands.
  • Krämer A; Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, Université Paris Cité, CNRS, 45 rue des Saints Pères, 75006 Paris, France.
  • Knapp S; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona 08036, Spain.
  • Meijer L; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona 08036, Spain.
J Med Chem ; 66(23): 15648-15670, 2023 12 14.
Article en En | MEDLINE | ID: mdl-38051674
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Down / Enfermedad de Alzheimer Límite: Animals Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Down / Enfermedad de Alzheimer Límite: Animals Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Francia